Back to Search
Start Over
The use of hemospray in portal hypertensive bleeding; a case series.
- Source :
-
Journal of Hepatology . Feb2014, Vol. 60 Issue 2, p457-460. 4p. - Publication Year :
- 2014
-
Abstract
- Abstract: Hemospray is a haemostatic agent licensed for endoscopic haemostasis of non-variceal upper gastrointestinal bleeding (NVUGIB) in Europe and Canada. Hemospray has been shown to be safe and effective in achieving haemostasis in bleeding peptic ulcers in a prospective clinical study and several further case series have described the use of hemospray in other non-variceal causes of gastrointestinal bleeding. Portal hypertensive gastropathy and colopathy are common in patients with portal hypertension. As hemospray is an easy to apply, non-contact method, which can cover large areas of mucosa, it may be of benefit in acute non-variceal portal hypertensive bleeding. We present data from the first four consecutive patients presenting to our institution with acute haemorrhage secondary to non-variceal diffuse portal hypertensive bleeding treated with hemospray. [Copyright &y& Elsevier]
Details
- Language :
- English
- ISSN :
- 01688278
- Volume :
- 60
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Journal of Hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 93687872
- Full Text :
- https://doi.org/10.1016/j.jhep.2013.10.008